Skip to main content

Beta-lactams for Tuberculosis Treatment

Searching for OpenAIRE data...


Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening

Author(s): María Pilar Arenaz-Callao, Rubén González del Río, Ainhoa Lucía Quintana, Charles J. Thompson, Alfonso Mendoza-Losana, Santiago Ramón-García
Published in: PLOS Neglected Tropical Diseases, 13/1, 2019, Page(s) e0007126, ISSN 1935-2735
Publisher: PLOS neglected tropical diseases
DOI: 10.1371/journal.pntd.0007126

The FICI paradigm: Correcting flaws in antimicrobial in vitro synergy screens at their inception

Author(s): Marta Gómara, Santiago Ramón-García
Published in: Biochemical Pharmacology, 163, 2019, Page(s) 299-307, ISSN 0006-2952
Publisher: Elsevier BV
DOI: 10.1016/j.bcp.2019.03.001

Sanfetrinem, repurposing an oral beta-lactam with intracellular activity for the treatment of tuberculosis

Author(s): Ramon-Garcia, Santiago, Dr (presenter); Bates, Robert, Dr; González del Río, Rubén, Mr; Gamallo, Pablo, Dr; Mendoza-Losana, Alfonso, Dr; Ferrer-Bazaga, Santiago, Dr; Thompson, Charles, Prof; Barros, David, Dr
Published in: ABSTRACT BOOK | 50th World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (The Union), 30 OCTOBER – 02 NOVEMBER 2019, 2019, Page(s) S591, ISSN 1027-3719
Publisher: International Union Against Tuberculosis and Lung Disease